HSP90AA1 and cancer: The dichotomy of Ag presentation (MHCI versus MHCII presentation of exogenous Ag) regulated by HSP70 and HSP90 might be associated with cross-priming and cross-tolerance, which would give rise to differential outcomes in the onset of autoimmune disease as well as in host defense against cancer and infectious disease.